hrcak mascot   Srce   HID

Pregledni rad

ROLE OF NEOADJUVANT CHEMOTHERAPY IN THE ADVANCED OVARIAN CANCER

Višnja Mataga
Višnja Matković

Puni tekst: hrvatski, pdf (201 KB) str. 0-0 preuzimanja: 62* citiraj
APA 6th Edition
Mataga, V. i Matković, V. (2013). ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA. Liječnički vjesnik, 135 (1-2), 0-0. Preuzeto s https://hrcak.srce.hr/172462
MLA 8th Edition
Mataga, Višnja i Višnja Matković. "ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA." Liječnički vjesnik, vol. 135, br. 1-2, 2013, str. 0-0. https://hrcak.srce.hr/172462. Citirano 17.10.2019.
Chicago 17th Edition
Mataga, Višnja i Višnja Matković. "ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA." Liječnički vjesnik 135, br. 1-2 (2013): 0-0. https://hrcak.srce.hr/172462
Harvard
Mataga, V., i Matković, V. (2013). 'ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA', Liječnički vjesnik, 135(1-2), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172462 (Datum pristupa: 17.10.2019.)
Vancouver
Mataga V, Matković V. ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA. Liječnički vjesnik [Internet]. 2013 [pristupljeno 17.10.2019.];135(1-2):0-0. Dostupno na: https://hrcak.srce.hr/172462
IEEE
V. Mataga i V. Matković, "ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA", Liječnički vjesnik, vol.135, br. 1-2, str. 0-0, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/172462. [Citirano: 17.10.2019.]

Sažetak
Primary surgery is still thought as cornerstone in treating locally advanced epithelial ovarian cancer. Subsequent to surgery is usually chemotherapy. Survival of patients with advanced epithelial ovarian cancer, according to International Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV, who make over 75% of total patients with ovarian cancer is still unsatisfactory. With these patients it is often impossible to perform adequate resection of all changes in the abdomen (optimal debulking) and so is the effectiveness of chemotherapy decreased. Therefore as a possible optimal approach appears neoadjuvant chemotherapy (NAC) that leads to the decreasing of the primary tumour and possible metastasis in the abdomen. With such an approach an operation procedure is shorter and easier after 3–4 cycles of chemotherapy with a stronger possibility of optimal »debulking«.

Ključne riječi
Ovarian neoplasms – pathology, drug therapy, surgery; Neoplasms, glandular and epithelial – pathology, drug therapy, surgery; Antineoplastic agents – therapeutic use; Neoadjuvant therapy; Neoplasm staging; Gynecologic surgical procedures

Hrčak ID: 172462

URI
https://hrcak.srce.hr/172462

[hrvatski]

Posjeta: 164 *